Pricing Log in Create free account
Saturday 17 October 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 2.48%, free cash flow grew 17.4% and total debt rose 37.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

79.20 0.78 +0.99%
Market cap
$32.4B
P/E
13.0×
Fwd P/E
12.3×
Dividend yield
2.64%
F-score
7/9
Altman Z
5.73
Beneish M
−2.45
Dividend safety
88/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zoetis Inc. (ZTS) Operating margin

Alert me on Operating margin

Zoetis Inc.'s operating margin over the twelve months to 30 June 2026 was 37.1%, down 0.7 percentage points from fiscal 2025 (37.8%). Over the past ten years it has ranged from 14.0% (fiscal 2015) to 37.8% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 37.8% 1.56
FY2024 36.3% (0.88)
FY2023 37.2% 1.55
FY2022 35.6% 0.73
FY2021 34.9% 1.52
FY2020 33.4% 1.03
FY2019 32.3% (0.22)
FY2018 32.6% 0.52
FY2017 32.0% 3.51
FY2016 28.5% 14.48

Quarterly newest first

Period Operating margin Change (points)
Jun 2026 37.6% 1.31
Mar 2026 36.3% 0.97
Dec 2025 35.3% (4.10)
Sep 2025 39.4% 0.37
42 more quarters

Against its own ten years

Low 14.0% High 37.8%
Ten-year median 33.4%
Current reading's percentile 83

Operating margin against peers

Company Operating margin
UTHR United Therapeutics Corporation compare 44.4%
ZTS Zoetis Inc. 37.1%
NBIX Neurocrine Biosciences, Inc. compare 23.6%
HLN Haleon PLC Sponsored ADR compare 17.9%
TAK Takeda Pharmaceutical Co. compare 11.6%
RDY Dr. Reddy's Laboratories Ltd compare 10.9%
TEVA Teva Pharmaceutical Industries Ltd. compare 8.77%
ELAN Elanco Animal Health Incorporated compare 1.61%
VTRS Viatris Inc. compare −0.59%
Drug Manufacturers Specialty & Generic industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on ZTS